Treatment with epoetin alfa reduces mortality in critically ill patients,a new study has shown.Epoetin alfa (40,000 units) or placebo was administered to 1,460 anaemic patients in the intensive care units of 115 medical centres in the US.After 29 days patients in the epoetin group had a greater increase in haemoglobin concentration than those in the placebo group (P<0.001) and mortality tended to be lower.
展开▼